Merck Revenue 2006-2019 | MKGAF

Merck annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Merck revenue for the quarter ending March 31, 2019 was $4.255B, a 6.22% decline year-over-year.
  • Merck revenue for the twelve months ending March 31, 2019 was $17.239B, a 2.86% decline year-over-year.
  • Merck annual revenue for 2018 was $17.521B, a 1.14% increase from 2017.
  • Merck annual revenue for 2017 was $17.324B, a 4.2% increase from 2016.
  • Merck annual revenue for 2016 was $16.626B, a 16.64% increase from 2015.
Merck Annual Revenue
(Millions of US $)
2018 $17,521
2017 $17,324
2016 $16,626
2015 $14,254
2014 $15,288
2013 $14,738
2012 $14,369
2011 $13,799
2010 $12,338
2009 $10,807
2008 $11,118
2007 $9,675
2006 $7,861
2005 $7,309
Merck Quarterly Revenue
(Millions of US $)
Q1 2019 $4,255
Q4 2018 $4,196
Q3 2018 $4,359
Q2 2018 $4,429
Q1 2018 $4,537
Q4 2017 $4,549
Q3 2017 $4,380
Q2 2017 $4,280
Q1 2017 $4,115
Q4 2016 $4,128
Q3 2016 $4,156
Q2 2016 $4,298
Q1 2016 $4,043
Q4 2015 $3,795
Q3 2015 $3,489
Q2 2015 $3,560
Q1 2015 $3,464
Q4 2014 $3,398
Q3 2014 $3,896
Q2 2014 $3,827
Q1 2014 $3,654
Q4 2013 $3,729
Q3 2013 $3,645
Q2 2013 $3,769
Q1 2013 $3,581
Q4 2012 $3,646
Q3 2012 $3,555
Q2 2012 $3,520
Q1 2012 $3,274
Q4 2011 $3,311
Q3 2011 $3,585
Q2 2011 $3,677
Q1 2011 $3,505
Q4 2010 $3,707
Q3 2010 $3,145
Q2 2010 $2,695
Q1 2010 $2,791
Q4 2009 $2,983
Q3 2009 $2,778
Q2 2009 $2,590
Q1 2009 $2,456
Q4 2008 $2,507
Q3 2008 $2,853
Q2 2008 $2,975
Q1 2008 $2,783
Q4 2007 $2,023
Q3 2007 $2,393
Q2 2007 $2,419
Q1 2007 $2,840
Q4 2006 $2,094
Q3 2006 $1,960
Q2 2006 $1,910
Q1 2006 $1,897
Q4 2005 $1,832
Q3 2005 $1,796
Q2 2005 $1,869
Q1 2005 $1,812
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.648B $17.522B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.871B 36.87
Astellas Pharma (ALPMY) Japan $26.681B 13.08
Takeda Pharmaceutical (TAK) Japan $26.123B 8.16
Grifols, S.A (GRFS) Spain $15.119B 19.29
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.535B 24.99
Ionis Pharmaceuticals (IONS) United States $9.706B 20.93
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.905B 0.00
IPSEN SA ADR (IPSEY) France $8.570B 0.00
Sage Therapeutics (SAGE) United States $8.368B 0.00
Catalent (CTLT) United States $8.137B 32.65
Jazz Pharmaceuticals (JAZZ) Ireland $7.634B 10.05
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.913B 17.66
FibroGen (FGEN) United States $3.876B 96.96
United Therapeutics (UTHR) United States $3.568B 0.00
Nektar Therapeutics (NKTR) United States $3.172B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.143B 11.27
Evotec AG (EVTCY) Germany $3.127B 42.81
Tilray (TLRY) Canada $3.044B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.957B 67.80
PTC Therapeutics (PTCT) United States $2.660B 0.00
Xencor (XNCR) United States $2.306B 50.28
Zogenix (ZGNX) United States $2.111B 0.00
Portola Pharmaceuticals (PTLA) United States $2.078B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.591B 57.91
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.500B 15.05
Corcept Therapeutics (CORT) United States $1.477B 20.30
Enanta Pharmaceuticals (ENTA) United States $1.416B 23.35
Ironwood Pharmaceuticals (IRWD) United States $1.372B 0.00
Heron Therapeutics (HRTX) United States $1.371B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.204B 0.00
ArQule (ARQL) United States $1.078B 0.00
Radius Health (RDUS) United States $1.066B 0.00
Aerie Pharmaceuticals (AERI) United States $1.065B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.904B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.724B 3.23
TherapeuticsMD (TXMD) United States $0.690B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.593B 0.00
Karyopharm Therapeutics (KPTI) United States $0.562B 0.00
Akebia Therapeutics (AKBA) United States $0.559B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.542B 0.00
Concordia (CXRXF) Canada $0.533B 0.00
Endo (ENDP) Ireland $0.512B 0.90
Indivior (INVVY) United States $0.487B 1.76
Aptorum Group (APM) China $0.472B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.453B 0.00
Dermira (DERM) United States $0.448B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.431B 19.58
ImmunoGen (IMGN) United States $0.424B 0.00
Siga Technologies (SIGA) United States $0.421B 0.98
Organogenesis Holdings (ORGO) United States $0.421B 0.00
Flexion Therapeutics (FLXN) United States $0.419B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Translate Bio (TBIO) United States $0.415B 0.00
ChemoCentryx (CCXI) United States $0.390B 0.00
Collegium Pharmaceutical (COLL) United States $0.386B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.325B 0.00
CV Sciences (CVSI) United States $0.317B 0.00
Xeris Pharmaceuticals (XERS) United States $0.313B 0.00
CannTrust Holdings (CTST) Canada $0.297B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.286B 0.00
KalVista Pharmaceuticals (KALV) United States $0.285B 0.00
Harpoon Therapeutics (HARP) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.266B 2.58
La Jolla Pharmaceutical (LJPC) United States $0.265B 0.00
OptiNose (OPTN) United States $0.263B 0.00
DURECT (DRRX) United States $0.261B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.252B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
Recro Pharma (REPH) United States $0.242B 0.00
Calithera Biosciences (CALA) United States $0.216B 0.00
Ocular Therapeutix (OCUL) United States $0.211B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.189B 0.00
Molecular Templates (MTEM) United States $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 29.03
Taiwan Liposome (TLC) Taiwan $0.165B 0.00
IMV INC (IMV) Canada $0.157B 0.00
Ardelyx (ARDX) United States $0.155B 0.00
Redhill Biopharma (RDHL) Israel $0.151B 0.00
GlycoMimetics (GLYC) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.131B 0.00
Generex Biotechnology (GNBT) United States $0.128B 0.00
Majesco Entertainment (PTE) United States $0.121B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.117B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.112B 0.00
MEI Pharma (MEIP) United States $0.110B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.105B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.091B 0.00
Cardiome Pharma (CORV) Canada $0.089B 0.00
Nivalis Therapeutics (ALPN) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 33.11
Genocea Biosciences (GNCA) United States $0.082B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.077B 0.00
Natural Alternatives (NAII) United States $0.075B 7.54
MediWound (MDWD) Israel $0.074B 0.00
Champions Oncology (CSBR) United States $0.072B 618.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Infinity Pharmaceuticals (INFI) United States $0.070B 0.00
Otonomy (OTIC) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Capnia (SLNO) United States $0.064B 0.00
Novan (NOVN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
Lipocine (LPCN) United States $0.058B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
CTI BioPharma (CTIC) United States $0.038B 0.00
Aclaris Therapeutics (ACRS) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Melinta Therapeutics (MLNT) United States $0.032B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.031B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.41
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00